Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club
Pharmaceutical Business Review
Return to: PBR Home
Search Refinements

News

View news from other Pharmaceutical sectors:
136-150 of 41049 results
GlaxoSmithKline Pharmaceuticals Q1 net income increases
08 May 2013 | By PBR Staff Writer
GlaxoSmithKline Pharmaceuticals in India has reported a net income from operations of Rs6.37bn ($118.06m) for the first quarter ended 31 March 2013 compared to Rs6.28bn ($116.39m) for the first quarter ended 31 March 2012.
Drug Research > Drug Discovery & Development > News
Novo Nordisk invests in Kalundborg plant for semaglutide production
08 May 2013 | By PBR Staff Writer
Novo Nordisk has announced the investment of additional DKK380m ($66.71m) in its Kalundborg plant in Denmark for the production of semaglutide.
Production & Manufacturing > Process & Production > News
Astellas, Drais partner to develop nocturia compound through Tacurion
08 May 2013 | By PBR Staff Writer
Astellas Pharma and Drais Pharmaceuticals have partnered to develop and commercialize third Astellas compound, being developed to treat nocturia through Tacurion Pharma.
Contract Research & Services > Contract Research > News
Ablynx commences pre-clinical development of allergic asthma candidate
08 May 2013 | By PBR Staff Writer
Ablynx has commenced pre-clinical development of ALX-0962, an anti- immunoglobulin E (IgE) nanobody, to treat severe allergic asthma and expects to begin Phase I development in the second half of 2014.
Drug Research > Drug Discovery & Development > News
CML, Inflamax to offer clinical research and bioanalytical services
08 May 2013 | By PBR Staff Writer
CML HealthCare has entered into a partnership with Canada-based Inflamax Research, a Contract Research Organization (CRO), to provide clinical research and bioanalytical services to the pharmaceutical and biotechnology industry.
Contract Research & Services > Contract Services > News
Cubist receives fast track status for antibiotic candidate
08 May 2013 | By PBR Staff Writer
Cubist Pharmaceuticals has received the US Food and Drug Administration (FDA) fast track status for its late-stage antibiotic candidate ceftolozane/tazobactam in the previously granted Qualified Infectious Disease Product (QIDP) indications, Hospital-Acquired Bacterial Pneumonia (HABP)/Ventilator-Associated Bacterial Pneumonia (VABP) and Complicated Urinary Tract Infections (cUTI).
Regulatory Affairs > News
Pfizer launches new purchasing website for its Viagra tablets
08 May 2013 | By PBR Staff Writer
Pfizer has launched its counterfeit medicine Viagra (sildenafil citrate) tablets home delivery, a new prescription-fulfillment website for Viagra.
News
Redx Pharma to open new R&D center in UK
08 May 2013 | By PBR Staff Writer
UK-based drug discovery and development company Redx Pharma is planning to open a new £10.5m research and development facility at AstraZeneca's Alderley Park site in Cheshire, England.
Drug Research > Drug Discovery & Development > News
Concert Pharmaceuticals, Celgene to develop deuterium-modified compounds
07 May 2013 | By PBR Staff Writer
Concert Pharmaceuticals and Celgene Corporation have entered into strategic collaboration to direct deuterium-modified compounds targeting cancer and inflammation.
Contract Research & Services > Contract Research > News
GlaxoSmithKline announces funding from Wellcome Trust
07 May 2013 | By PBR Staff Writer
GlaxoSmithKline (GSK) has announced a funding injection of up to £5m from the Wellcome Trust to support its open approach to discover and develop the treatments for certain diseases.
Drug Research > Drug Discovery & Development > News
MorphoSys reaches milestone in ophthalmology program with Novartis
07 May 2013 | By PBR Staff Writer
MorphoSys has reached a milestone in ophthalmology program for the development of HuCAL-derived, fully human antibody, with Novartis.
Contract Research & Services > Contract Research > News
Critical Outcome updates on R&D collaboration projects
07 May 2013 | By PBR Staff Writer
Critical Outcome Technologies has announced that all three of the collaboration research and development (R&D) projects announced in the fall of 2012 are on time and progressing.
Contract Research & Services > Contract Research > News
DVS Sciences introduces CyTOF 2 Mass Cytometer, MaxPar Panel Kits
07 May 2013 | By PBR Staff Writer
DVS Sciences has introduced the new CyTOF 2 Mass Cytometer and new MaxPar Panel Kits used specifically for simultaneous high-parameter single cell analysis.
Production & Manufacturing > Process & Production > News
Kinex, Zenith enter into collaborative licensing agreement
07 May 2013 | By PBR Staff Writer
Kinex Pharmaceuticals and Zenith Technology Corporation, through its affiliate ZenRx, have entered into collaborative licensing agreement granting Zenith Technology commercial rights to Oraxol and Oratecan in New Zealand and Australia.
Contract Research & Services > Contract Research > News
Pacira Pharmaceuticals announces positive results from Exparel studies
07 May 2013 | By PBR Staff Writer
Pacira Pharmaceuticals has announced the findings from two new studies supporting the use of Exparel infiltrated into the transversus abdominis plane for postsurgical pain management.
Drug Research > Drug Delivery > News
136-150 of 41049 results